Treatment of cystinosis with cysteamine. A pilot study determining dose and form of application

Helvetica Paediatrica Acta
|November 1, 1981
PubMed

Insights

Cysteamine treatment for nephropathic cystinosis in children shows promise. Gelatin capsules are an effective delivery method, with 50 mg/kg/day normalizing leukocyte cystine levels without side effects.

Area of Science:

  • Pediatric Nephrology
  • Medical Biochemistry

Background:

  • Nephropathic cystinosis is a rare genetic disorder characterized by lysosomal accumulation of cystine.
  • Current treatments focus on managing complications and slowing disease progression.

Observation:

  • A pilot study evaluated cysteamine treatment in three children with nephropathic cystinosis, two of whom had undergone renal transplantation.
  • The study aimed to identify a practical application form and effective dosage for cysteamine therapy.

Findings:

  • Cysteamine in gelatin capsules with silicic acid was the most acceptable formulation compared to syrup or suppositories.
  • A dosage of 50 mg/kg/day effectively reduced leukocyte cystine content, indicating therapeutic efficacy.
  • No adverse side effects were observed, even at higher doses (90 mg/kg/day).

Implications:

  • This study suggests a viable and well-tolerated cysteamine treatment regimen for nephropathic cystinosis.
  • Further research is needed to confirm its long-term efficacy in preventing disease progression, particularly in transplanted patients or pre-symptomatic infants.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...